Post-approval studies (Phase 4)Study completedNCT05657860
What this trial is testing
Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
Who this might be right for
Prader-Willi SyndromeAggressionSelf-Injurious Behavior+18 more
Maimonides Medical Center 15